Trial Profile
Phase II randomised clinical trial of personalized peptide vaccination in combination with Dai-kenchu-to for colorectal cancer patients resistant to standard therapies.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2019
Price :
$35
*
At a glance
- Drugs TU 100 (Primary) ; Colorectal cancer vaccine; Incomplete Freund's adjuvant
- Indications Colorectal cancer
- Focus Pharmacodynamics
- 30 Oct 2019 Status changed from active, no longer recruiting to completed.
- 07 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 14 Jun 2012 New trial record